Your session is about to expire
← Back to Search
Cognitive Training for Parkinson's Disease
N/A
Waitlist Available
Led By Sule Tinaz, MD, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 40 years
Diagnosis of idiopathic PD
Must not have
Hoehn & Yahr stage > 3 (i.e., able to stand and walk, but not fully independent)
History of head injury with loss of consciousness longer than a few minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 6 weeks, and 12 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trialwill explore if cognitive training can help people with PD better manage daily tasks by testing their brain & cognitive skills.
Who is the study for?
This trial is for people over 40 with Parkinson's Disease who are on stable medication. Participants must speak English, not be pregnant or breastfeeding, have no excessive alcohol use, and no metal implants that affect MRI scans. They should be able to lie flat for an hour and not have severe cognitive impairments or other neurological disorders.
What is being tested?
The study tests if mental imagery training and psychoeducation can improve thinking skills and brain function in daily activities for those with Parkinson's. It involves cognitive assessments and MRIs to measure the effects of the interventions.
What are the potential side effects?
Since this trial focuses on non-invasive cognitive training rather than medication, traditional side effects like nausea or headaches aren't expected. However, participants may experience fatigue or discomfort from long periods of concentration or lying still during MRI scans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 40 years old or older.
Select...
I have been diagnosed with Parkinson's disease.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My Parkinson's disease is advanced; I can stand and walk but need help.
Select...
I've had a head injury that made me unconscious for more than a few minutes.
Select...
I have specific symptoms suggesting a brain disorder not related to Parkinson's.
Select...
I cannot lie flat for an hour.
Select...
I have a history of a serious brain or nerve condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, 6 weeks, and 12 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 6 weeks, and 12 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Quality of life in Neurological Disorders (Neuro-QoL) Version 2 Cognitive Function scores
Brain
Secondary study objectives
Change in composite executive function test scores
Change in local and global functional connectivity-based graph measures
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mental ImageryExperimental Treatment1 Intervention
Group II: PsychoeducationActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,927 Previous Clinical Trials
3,031,701 Total Patients Enrolled
9 Trials studying Dementia
3,164 Patients Enrolled for Dementia
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,381 Previous Clinical Trials
652,219 Total Patients Enrolled
27 Trials studying Dementia
199,326 Patients Enrolled for Dementia
Sule Tinaz, MD, PhDPrincipal InvestigatorYale University